BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Ophthotech Corporation Announces First Patient Dosed In Zimura Phase 2/3 Study To Evaluate Treatment In Patients With Geographic Atrophy, An Advanced Form Of Dry Age-Related Macular Degeneration

  January 27, 2016

   · 

  4 min read
• Policy

  Merck & Co. Announces FDA Acceptance Of Biologics License Application For Bezlotoxumab, An Investigational Antitoxin For Prevention Of Clostridium Difficile Infection Recurrence

  January 27, 2016

   · 

  4 min read
• New Veeva Systems, Inc. CRM Suggestions, Now Available, Powers Sales Teams With Data-Driven Recommendations On Next Best Action And Channel

  January 27, 2016

   · 

  1 min read
• Business

  Ferring Pharmaceuticals And Karolinska Institute Sign Collaboration Agreement On The Development Of A Human Microbiome Translational Research Programme

  January 27, 2016

   · 

  1 min read
• Biotech Bay

  Agilent Wins Award For Innovation In Liquid Chromatography

  January 27, 2016

   · 

  2 min read
• BioMidwest

  James S. Mcdonnell Foundation Announces 2015 Grants For The 21st Century Science Initiative Awards

  January 27, 2016

   · 

  5 min read
• BioForest

  FDA Approves Aortica To Supply Aortafit System For Starnes’ Physician-Sponsored IDE Study

  January 27, 2016

   · 

  4 min read
• Pharm Country

  Ono Pharmaceutical Company, Ltd. Selects Medidata To Power Clinical Trials Exploring Additional Cancer Indications For Immunotherapy Drug OPDIVO (Nivolumab)

  January 27, 2016

   · 

  1 min read
• Drug Development

  Cardiome Pharma Corp. Announces Filing Of Orphan Drug Application For Oral Vernakalant With U.S. FDA

  January 27, 2016

   · 

  5 min read
• FDA

  Vertex Release: Health Canada Approves PrORKAMBI (Lumacaftor/Ivacaftor) - The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis For People Ages 12 And Older With Two Copies Of The F508del Mutation

  January 27, 2016

   · 

  9 min read